Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

P289: Prevalence and risk factors of hepatitis c virus infection in chronic hemodialysis patients at the university teaching hospital of point g, Bamako, Mali

  • 1,
  • 2,
  • 1, 2,
  • 1,
  • 1 and
  • 2
Antimicrobial Resistance and Infection Control20132 (Suppl 1) :P289

  • Published:


  • Hepatitis
  • Infectious Disease
  • Virus Infection
  • Serum Sample
  • Blood Transfusion


The objective of this prospective study conducted in November 2008, was to determine the prevalence and the factors associated with Hepatitis C Virus (HCV) infection in chronic hemodialysis patients.


The study was carried out in the hemodialysis unit of the university teaching hospital of Point G. Serum samples were tested for anti-HCV antibody, anti-HIV antibody and HBs Ag using enzyme immunoassay methods (ELISA) at the laboratory of immunology of the National Blood Transfusion Service of Bamako. The following parameters were assessed: initial nephropathy, duration of the dialysis, history of blood transfusion, number of blood units transfused since the beginning of the dialysis, history of nosocomial exposure.


A total of 66 patients were enrolled. The mean age of the patients was 42,27±14, 8 years, with a male to female sex-ratio of 1,44. Anti-HCV antibodies were found in 13 chronic hemodialysis patients, leading to a prevalence of 19,7%. A significant association was found between the bearing of HCV and the duration of the dialysis.


These results indicate that hepatitis C is frequent in the chronic hemodialysis patients of the university teaching hospital of Point G, and that the duration of dialysis constitutes the main factor associated with the contamination by the HCV.


Authors’ Affiliations

National Center for Blood Transfusion, University Hospital of Point G, Bamako, Mali
Department of Nephrology, University Hospital of Point G, Bamako, Mali


© Baby et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.